Document is current
Any future updates will be listed below
-
Authors
Qin, Xiaojian
Ji, Dongmei
Gu, Weijie
Han, Weiqing
Luo, Hong
Du, Chuanjun
Zou, Qing
Sun, Zhongquan
He, Chaohong
Zhu, Shaoxing
Chong, Tie
Yao, Xin
Wan, Ben
Yang, Xinfeng
Bai, Aobing
Jin, Chunlei
Zou, Jianjun
Ye, Dingwei http://orcid.org/0000-0003-4974-3780
-
Funding
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- License Information
-
More Information
Article History
Received: 15 November 2021
Accepted: 18 January 2022
First Online: 4 March 2022
Declarations
:
: The study was done in accordance with Declaration of Helsinki and the Good Clinical Practice Guideline. The protocol and all amendments were approved by the institutional review board or independent ethics committee of each study site (Fudan University Shanghai Cancer Center, Hunan Cancer Hospital, Chongqing Cancer Hospital, The Second Affiliated hospital of Zhejiang University School of Medicine, Jiangsu Cancer Hospital, Huadong Hospital Affiliated to Fudan University, Cancer Hospital of Henan Province, Zhejiang Cancer Hospital, The Second Affiliated Hospital of Xi’an Jiaotong University, Tianjin Cancer Hospital, and Beijing Hospital). All patients provided written informed consent.
: Not applicable.
: Xinfeng Yang, Aobing Bai, Chunlei Jin, and Jianjun Zou are employees of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Other co-authors declare no competing interests.
